Antibody targeting CD22 and CD79B

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12180278
APP PUB NO 20220306738A1
SERIAL NO

17702042

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are multispecific antibodies, that bind to CD79b and CD22, polynucleotides encoding them, vectors, host cells, methods of making and using them.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JANSSEN BIOTECH INC80/850 RIDGEVIEW DRIVE HORSHAM PA 19044

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bednar, Kyle J Conshohocken, US 2 0
Ganesan, Rajkumar Blue Bell, US 74 44
Kumar, Naresh Warrington, US 128 592
Singh, Sanjaya Blue Bell, US 142 767
Yang, Danlin Philadelphia, US 9 16

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jun 30, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 30, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 30, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00